Open house Arzneimittelrabattverträge zum Wirkstoff Interferon beta-1a, subkutane Injektion, ATC L03AB07

TENDER DESCRIPTION

AOK Rheinland-Pfalz/Saarland - The Health Insurance Fund offers rebate contracts for the aforementioned active substance to all interested pharmaceutical companies without a selection decision. The contracts are concluded within the framework of an "Open House Model." The offered contracts are non-exclusive; contracts with all market participants (pharmaceutical companies) are wished by AOK Rheinland-Pfalz/Saarland - The Health Insurance Fund. In the Open House Model, uniform conditions apply to all participants. Contract contents, conditions and access procedures are uniform - individual negotiations are not conducted. The contract durations are a maximum of 24 months; the earliest contract start is 01.10.2026. All contracts end at the latest 24 months after the day of the earliest contract start, regardless of the date of the respective contract conclusion. Joining or contract conclusion can take place within the 24-month period on the first day of each month. There is a right of termination with 6 weeks' notice to the end of the month in accordance with the provisions of the contract. Further information on termination options is included in the contract documents. AOK…

TENDER BRIEF

TENDER DOCUMENTS